Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

Menarche (age at onset)

SATB2 · rs17266097

Strength of the evidence

1 / 4

Its strongest genetic-study result is p = 10−18, with 3 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied Up to 182,413 European ancestry females.

The effect Each copy of the T allele shifted the measure 0.04 higher (95% confidence interval 0.03-0.05); p = 3 × 10−18.

How common The T allele had a frequency of about 42% in the people studied.

Where it sits Chromosome 2, band 2q33.1 — in an intron of SATB2.

How common each version is

CT
Korean KRGDB
C 87.4% · T 12.6%
Korean Korea4K
C 86.3% · T 13.7%
Japanese ToMMo
C 91.0% · T 9.0%
Vietnamese
C 81.9% · T 18.1%
World gnomAD
C 71.5% · T 28.5%
World 1000 Genomes
C 81.1% · T 18.9%
World TOPMed
C 74.0% · T 26.0%

By ancestry gnomAD

East Asian
C 83.6% · T 16.4%
European (non-Finnish)
C 59.9% · T 40.2%
African / African American
C 92.5% · T 7.5%
South Asian
C 80.8% · T 19.2%
Admixed American (Latino)
C 72.9% · T 27.1%
Middle Eastern
C 77.2% · T 22.8%
Finnish
C 53.6% · T 46.4%
Ashkenazi Jewish
C 66.5% · T 33.5%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

C/C No copy of the version the research linked to Menarche (age at onset). This is the starting point the study compared everyone against.
C/T One copy of the version the research linked to Menarche (age at onset). That is a smaller link than two copies.
T/T Two copies of the version the research linked to Menarche (age at onset). That is the strongest link of the three results. A link in a study is not a diagnosis.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Menarche (age at onset) (rs17266097). MyGeneLog™. https://www.mygenelog.com/variants/rs17266097

← See all variants